Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature - Poll - MDSpire

Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature

  • By

  • Fenge Li

  • Yue Xu

  • Yupeng Wang

  • Ning Mu

  • Mei Liu

  • Weihong Feng

  • Yongming Xue

  • Shengnan Wu

  • Xinyi Wang

  • Gregory Lizee

  • Chunhua Ma

  • April 23, 2026

  • 0 min

Share

Original Source(s)

Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature

  • by Fenge Li, Yue Xu, Yupeng Wang, Ning Mu, Mei Liu, Weihong Feng, Yongming Xue, Shengnan Wu, Xinyi Wang, Gregory Lizee, Chunhua Ma

  • April 23, 2026

Related Content

Retrospective Study of Immunoembolization for Liver-Dominant Metastatic Uveal Melanoma at a Single Institution

Error in Tables 2 and 3

  • May 1, 2026

A model combining deep learning and ensemble learning for melanoma recognition via dermoscopy